Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ).
Shanghai HeartCare Medical Technology Corporation Limited announced a positive profit alert, expecting a net profit of not less than RMB40 million for the first half of 2025, marking a significant turnaround from a net loss in the same period of 2024. This improvement is attributed to business growth and a decrease in the expense ratio. Additionally, the company proposes to utilize its capital reserve to offset losses, pending shareholder approval at an upcoming extraordinary general meeting.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corporation Limited is a company incorporated in China, operating in the medical technology industry. It focuses on developing and providing medical solutions and technologies, with a market focus on healthcare advancements.
Average Trading Volume: 133,751
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.05B
For detailed information about 6609 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money